X4 Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: RSI rebound, MACD bullish cross. There are 2 published signal records.
X4 Pharmaceuticals last closed at $2.91 (+4.30%) on 2026-10-09. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -3.9×. Its overall grade ranks 357 of 738 stocks in Healthcare.
About this company
X4 Pharmaceuticals last closed at $2.91 (+4.30%) on 2026-10-09. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 357/738
Valuation grade B-
Related stocks
- MerckCompetitor
면역항암제·항암 신약 개발에서 경쟁하는 대형 제약사
- Bristol Myers SquibbCompetitor
면역항암 및 희귀질환 신약 분야의 주요 경쟁사
- AmgenCompetitor
면역·종양 치료제 개발에서 경쟁하는 대형 바이오기업
About X4 Pharmaceuticals
- What technical signals does X4 Pharmaceuticals (XFOR) have?
- X4 Pharmaceuticals current technical signals: RSI rebound, MACD bullish cross.
- Is X4 Pharmaceuticals a cup-and-handle pattern?
- No. X4 Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for X4 Pharmaceuticals?
- Market cap: $254.44M. Trailing 12 months PER: -3.9×. Latest quarter PBR: 2.27×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about X4 Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.